Human Holdings Co (2415) Q1 2026 earnings summary

Executive summary

• Revenue increased by 4.0% year-over-year to ¥25,626 million, with all segments posting higher sales and operating profit rising across the board.

• Operating profit grew 19.3% year-over-year to ¥646 million, and ordinary profit rose 37.6% to ¥782 million.

• Net income attributable to parent surged 57.3% to ¥407 million, with earnings per share at ¥39.23, up from ¥24.94.

• Significant growth in ordinary profit was aided by ¥158 million in subsidies in the nursing care segment, booked as non-operating income.

Financial highlights

• Gross profit increased to ¥6,617 million from ¥6,234 million year-over-year.

• Selling, general and administrative expenses rose to ¥5,971 million from ¥5,692 million.

• Revenue: ¥25,626 million (+4.0% YoY); Operating profit: ¥646 million (+19.3% YoY); Ordinary profit: ¥782 million (+37.6% YoY); Net income: ¥407 million (+57.3% YoY).

• Gross margin and operating margin improved, with operating margin rising from 2.2% to 2.5% year-over-year.

• Total assets as of June 30, 2025, were ¥50,785 million, with net assets at ¥17,718 million.

Outlook and guidance

• Full-year net sales forecasted at ¥103,600 million, a 3.3% increase year-over-year.

• Operating profit projected at ¥3,600 million (up 5.7%), ordinary profit at ¥3,700 million (up 3.5%).

• Profit attributable to owners of parent expected to decrease by 4.1% to ¥2,500 million.

• Full-year earnings per share forecasted at ¥240.90; annual dividend forecast set at ¥72.50 per share.

• Forward-looking statements are subject to risks and uncertainties; actual results may differ significantly due to various factors.